Suppr超能文献

用于肛瘘的纤维蛋白胶:长期结果

Fibrin glue for anal fistulas: long-term results.

作者信息

Sentovich Stephen M

机构信息

Section of Colon and Rectal Surgery, Department of Surgery, Boston University School of Medicine, Boston, MA, USA.

出版信息

Dis Colon Rectum. 2003 Apr;46(4):498-502. doi: 10.1007/s10350-004-6589-y.

Abstract

PURPOSE

The aim of this study was to evaluate the long-term success and complication rate of fibrin-glue treatment of anal fistulas.

METHODS

Patients with an anal fistula presenting to a single surgeon over a three-year period were enrolled in this study. At their first operation, all 48 patients (26-72 years old) underwent anoscopy, biopsy, destruction of the internal gland, and placement of a draining seton. Approximately two months later after preoperative bowel preparation, the seton was removed, the internal opening closed with a single suture, and fibrin glue instilled by way of the external opening to seal the fistula tract. Patients were followed closely to document the results of treatment and any complications. Long-term follow-up was done by telephone interview.

RESULTS

Cause of the anal fistula was cryptoglandular in 36 (75 percent) patients, Crohn's disease in 5 (10 percent), and miscellaneous in 7 (15 percent). Median follow-up was 22 months (range, 6-46 months). After a single treatment with fibrin glue, 29 (60 percent) fistulas closed. Retreatment with fibrin glue brought the successful number of fistula tracts closed to 33 (69 percent). The 15 (29 percent) patients who failed either one or two treatments with fibrin glue were successfully treated with either fistulotomy or advancement flap. Bowel function and fecal incontinence were not altered by the fibrin-glue treatment. In one patient who failed fibrin glue, the fibrin-glue treatment may have created a more complicated fistula tract. Late recurrences (>6 months) occurred in three (6 percent) patients, two of whom were successfully retreated with fibrin glue.

CONCLUSIONS

Fibrin-glue treatment of anal fistulas is successful in up to 69 percent of patients if initial failures are retreated. This sphincter-saving technique is associated with minimal complications and no functional detriment. Late recurrences are unusual.

摘要

目的

本研究旨在评估纤维蛋白胶治疗肛瘘的长期成功率及并发症发生率。

方法

本研究纳入了在三年期间由同一位外科医生诊治的肛瘘患者。所有48例患者(年龄26 - 72岁)在首次手术时均接受了肛门镜检查、活检、内口腺体破坏及引流挂线术。术前肠道准备约两个月后,拆除挂线,用单根缝线闭合内口,并通过外口注入纤维蛋白胶以封闭瘘管。对患者进行密切随访以记录治疗结果及任何并发症。通过电话访谈进行长期随访。

结果

肛瘘病因中,36例(75%)为腺源性,5例(10%)为克罗恩病,7例(15%)为其他原因。中位随访时间为22个月(范围6 - 46个月)。单次使用纤维蛋白胶治疗后,29例(60%)瘘管闭合。再次使用纤维蛋白胶治疗使成功闭合的瘘管数量增至33例(69%)。15例(29%)接受一至两次纤维蛋白胶治疗失败的患者,通过肛瘘切开术或推进皮瓣术成功治愈。纤维蛋白胶治疗未改变肠道功能及大便失禁情况。在1例纤维蛋白胶治疗失败的患者中,该治疗可能导致了更复杂的瘘管。3例(6%)患者出现晚期复发(>6个月),其中2例再次使用纤维蛋白胶治疗成功。

结论

如果对初次治疗失败的患者进行再次治疗,纤维蛋白胶治疗肛瘘的成功率可达69%。这种保留括约肌的技术并发症极少,且无功能损害。晚期复发并不常见。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验